Academic Journal
A phase 2 trial of durvalumab treatment following radiation monotherapy in patients with non-small cell lung cancer ineligible for stage III chemoradiotherapy: The SPIRAL-RT study
العنوان: | A phase 2 trial of durvalumab treatment following radiation monotherapy in patients with non-small cell lung cancer ineligible for stage III chemoradiotherapy: The SPIRAL-RT study |
---|---|
المؤلفون: | Yamada, Tadaaki, Goto, Yasuhiro, Tanaka, Hiroshi, Kimura, Hideharu, Minato, Koichi, Gyotoku, Hiroshi, Honda, Takeshi, Watanabe, Satoshi, Morimoto, Kenji, Kiyomi, Fumiaki, Uchino, Junji, Takayama, Koichi |
المساهمون: | AstraZeneca KK, AstraZeneca |
المصدر: | European Journal of Cancer ; volume 195, page 113373 ; ISSN 0959-8049 |
بيانات النشر: | Elsevier BV |
سنة النشر: | 2023 |
المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
DOI: | 10.1016/j.ejca.2023.113373 |
الاتاحة: | http://dx.doi.org/10.1016/j.ejca.2023.113373 https://api.elsevier.com/content/article/PII:S0959804923006755?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S0959804923006755?httpAccept=text/plain |
Rights: | https://www.elsevier.com/tdm/userlicense/1.0/ ; http://creativecommons.org/licenses/by/4.0/ |
رقم الانضمام: | edsbas.9F060AAD |
قاعدة البيانات: | BASE |
DOI: | 10.1016/j.ejca.2023.113373 |
---|